Trial intelligence / Profile preview

EPs 7630 solution for acute rhinopharyngitis in adults

2007-005579-33Phase 3Completed

Sponsor
Schwabe Group
Start
Jun 2008
Countries
1
01

Overview

Phase 3 trial of pelargonium sidoides extract, sponsored by Schwabe Group. Primary endpoint: Area under the curve of total rhinopharyngitis-relevant symptom score. Started Jun 2008; status: completed.

02

Drugs

pelargonium sidoides extract

Beyond the preview

Go deeper on 2007-005579-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005579-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call